These expanded CD8+ T cells demonstrated a significant reduction in the survival of corresponding PDOs, highlighting the utility of this coculture model for assessing immuno‐oncology therapy responses in a personalized manner and for generating patient‐specific tumor‐killing T cells. Here, CD8A is linked to neoplasm.